GPS Pharma Private Limited
About GPS Pharma Private Limited
Data last updated:
GPS Pharma Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the bfsi segment of the financial services sector. It was incorporated on 18 July 1994.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PTC060300. The company has 2 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹20 Lakh and a paid-up capital of ₹15 Lakh. It was led by directors Sujoy Broota and Gur Partap Singh.
Its last annual general meeting (AGM) was held on 04 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at I – 9 Ugf Kiran Bulding Ajadpur Commercial Complex, New Delhi, Delhi, India – 110033.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.36 Lakh, a growth of 46% compared to the previous year. For the same year it recorded a net loss of ₹23.38 Lakh and EBITDA of -₹23.18 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 36% over three years and 50% over five years.
As per MCA filings, the company had satisfied charges of ₹2 Lakh on record.
Company details
Contact details
GPS Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressI – 9 Ugf Kiran Bulding Ajadpur Commercial Complex, New Delhi, Delhi, India – 110033
- IndustryFinancial Services, Bfsi, Commercial Banks
To see the full contact details of GPS Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of GPS Pharma is professional, scientific and technical. In detail, this covers management consultancy activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities |
Financials of GPS Pharma Private Limited
FY 2023 filings availableGPS Pharma Private Limited reported revenue of ₹2.36 Lakh (up 46% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 46% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 50%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹23.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹23.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of GPS Pharma Private Limited, buy the company report.
Board of directors of GPS Pharma Private Limited
GPS Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujoy Broota | Director | 10 Sep 2018 | 8 Years 1 Months | As last reported |
| Gur Partap Singh | Director | 18 Jul 1994 | 32 Years 3 Months | As last reported |
Peer comparison
GPS Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (management consultancy activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hap Infra Projects Private Limited | ₹2.37 Lakh (FY 2016) | 16.0% | Vijayawada, Andhra Pradesh, India | |||
| Marshall Die Casting Private Limited | ₹2.37 Lakh (FY 2025) | -2.0% | New Delhi, Delhi, India | |||
| Daatar Consultants OPC Private Limited | ₹2.37 Lakh (FY 2016) | Gurgaon, Haryana, India | ||||
| Kalita360 Solutions (OPC) Private Limited | ₹2.36 Lakh (FY 2025) | -57.0% | Bangalore, Karnataka, India | |||
| Induson Technosolutions Private Limited | ₹2.36 Lakh (FY 2019) | -52.0% | Jhunjhunu, Rajasthan, India | |||
| GPS Pharma Private Limitedthis company | ₹2.36 Lakh (FY 2023) | -₹23.38 Lakh | 46.0% | New Delhi, Delhi, India | ||
| Oxygenta Info Tech Private Limited | ₹2.35 Lakh (FY 2018) | -3.0% | New Delhi, Delhi, India | |||
| Bizsmart Solutions India Private Limited | ₹2.35 Lakh (FY 2017) | -49.0% | Bangalore, Karnataka, India | |||
| Straw Markets Advisory Private Limited | ₹2.35 Lakh (FY 2018) | -58.0% | Gandhinagar, Gujarat, India | |||
| Arix Capital Limited | ₹2.34 Lakh (FY 2024) | -23.0% | Rajkot, Gujarat, India | |||
| Bism Horizon Research Services Private Limited | ₹2.34 Lakh (FY 2024) | -47.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of GPS Pharma Private Limited, buy the company report.
Auditor
GPS Pharma Private Limited is audited by MITTAL VAISH & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MITTAL VAISH & CO | FY 2017 | 013622N |
Shareholding
The shareholding of GPS Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of GPS Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Dec 2006 | 10163659 | Punjab National Bank | ₹2 Lakh | Satisfied |
To see the full charge records of GPS Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving GPS Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for GPS Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
GPS Pharma has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of GPS Pharma Private Limited, buy the company report.
Recent activity
GPS Pharma Private Limited has 5 board changes on record since 1994: 2 appointments and 3 cessations. The latest: Sujoy Broota ceased to be Additional Director on 29 Sep 2018.
Frequently asked questions
GPS Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
GPS Pharma was a private limited company based in New Delhi, Delhi, India. The company worked in bfsi, within the financial services industry. It was incorporated on 18 July 1994 and is registered under CIN U74899DL1994PTC060300. The company has been struck off by the Registrar of Companies and is no longer operational.
GPS Pharma had 2 directors:
- Sujoy Broota - Director
- Gur Partap Singh - Director
The CIN (Corporate Identification Number) of GPS Pharma is U74899DL1994PTC060300. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of GPS Pharma is at I – 9 Ugf Kiran Bulding Ajadpur Commercial Complex, New Delhi, Delhi, India – 110033.
GPS Pharma was incorporated on 18 July 1994. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of GPS Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 04 September 2023. Year-wise statements from 2015 are in the company report.
No. GPS Pharma has 2 GST registrations on record and all of them are cancelled or inactive.
GPS Pharma operated in the financial services industry, in the bfsi segment. It worked in this industry before it was struck off.
The peers of GPS Pharma by revenue are Hap Infra Projects Private Limited, Marshall Die Casting Private Limited, Daatar Consultants OPC Private Limited, Kalita360 Solutions (OPC) Private Limited, Induson Technosolutions Private Limited and 5 more, all in the same principal business activity (management consultancy activities).
Sujoy Broota ceased to be Additional Director on 29 Sep 2018. Ishneet Kaur ceased to be Director on 10 Sep 2018. Simran Kaur ceased to be Director on 10 Sep 2018. GPS Pharma has 5 board changes on record in total.